TrialHaematologica2024

Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study.

Ali T Taher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.